Skip to content

Non-invasive Spinal Cord Stimulation for Spasticity Control and Augmentation of Voluntary Motor Control in Individuals With Multiple Sclerosis

Non-invasive Spinal Cord Stimulation for Spasticity Control and Augmentation of Voluntary Motor Control in Individuals With Multiple Sclerosis

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04486209
Acronym
noSpasMS
Enrollment
15
Registered
2020-07-24
Start date
2017-12-27
Completion date
2020-07-02
Last updated
2023-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

neuromodulation, spinal cord stimulation, walking function, spasticity

Brief summary

Epidural spinal cord stimulation (SCS) is currently regarded as one of the most promising intervention methods to improve motor function in individuals with severe spinal cord injury. In parallel, an increasing number of studies is suggesting that noninvasive SCS can improve spasticity and residual motor control in the same subject population. The present study explores whether single sessions of noninvasive SCS would improve walking performance and ameliorate spasticity in individuals with multiple sclerosis.

Interventions

DEVICEtranscutaneous spinal cord stimulation

electrical stimulation of the lumbosacral spinal cord through surface electrodes

Sponsors

Neurological Center, Otto Wagner Hospital
CollaboratorUNKNOWN
Medical University of Vienna
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* confirmed diagnosis of relapsing-remitting, primary- or secondary-progressive MS * lower-limb spasticity

Exclusion criteria

* acute relapse of MS * other neuromuscular diseases * active and passive implants at vertebral level T9 or caudally * dermatological issues at stimulation site * pregnancy

Design outcomes

Primary

MeasureTime frame
Modified Ashworth Scale24 hours

Secondary

MeasureTime frame
10-m walk test24 hours
2-min walk test24 hours
Timed up an go test24 hours

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026